These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

877 related items for PubMed ID: 28735160

  • 1. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
    Read FA, Boyd RN, Barber LA.
    Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160
    [Abstract] [Full Text] [Related]

  • 2. Botulinum neurotoxin type A responders among children with spastic cerebral palsy: Pattern-specific effects.
    Papageorgiou E, Peeters N, Staut L, Molenaers G, Ortibus E, Van Campenhout A, Desloovere K.
    Eur J Paediatr Neurol; 2024 Mar; 49():131-140. PubMed ID: 38518417
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of group versus individual physiotherapy following lower limb intra-muscular Botulinum Toxin-Type A injections for ambulant children with cerebral palsy: A single-blind randomized comparison trial.
    Thomas RE, Johnston LM, Sakzewski L, Kentish MJ, Boyd RN.
    Res Dev Disabil; 2016 Mar; 53-54():267-78. PubMed ID: 26955912
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
    Lukban MB, Rosales RL, Dressler D.
    J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
    [Abstract] [Full Text] [Related]

  • 5. Intramuscular botulinum toxin prior to comprehensive rehabilitation has no added value for improving motor impairments, gait kinematics and goal attainment in walking children with spastic cerebral palsy.
    Schasfoort F, Pangalila R, Sneekes EM, Catsman C, Becher J, Horemans H, Stam HJ, Dallmeijer AJ, Bussmann JBJ.
    J Rehabil Med; 2018 Aug 22; 50(8):732-742. PubMed ID: 30080235
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
    Koman LA, Smith BP, Williams R, Richardson R, Naughton M, Griffin L, Evans P.
    J Hand Surg Am; 2013 Mar 22; 38(3):435-46.e1. PubMed ID: 23428186
    [Abstract] [Full Text] [Related]

  • 8. Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy.
    Büyükavcı R, Büyükavcı MA.
    Acta Neurol Belg; 2018 Sep 22; 118(3):429-433. PubMed ID: 29694645
    [Abstract] [Full Text] [Related]

  • 9. Treatment with botulinum toxin in children with cerebral palsy: a qualitative study of parents' experiences.
    Lorin K, Forsberg A.
    Child Care Health Dev; 2016 Jul 22; 42(4):494-503. PubMed ID: 27198886
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin type A injections for treatment of spastic equinus in cerebral palsy: a secondary analysis of factors predictive of favorable response.
    Sätilä H, Huhtala H.
    Am J Phys Med Rehabil; 2010 Nov 22; 89(11):865-72. PubMed ID: 20736816
    [Abstract] [Full Text] [Related]

  • 11. Effects of leg muscle botulinum toxin A injections on walking in children with spasticity-related cerebral palsy: a systematic review.
    Ryll U, Bastiaenen C, De Bie R, Staal B.
    Dev Med Child Neurol; 2011 Mar 22; 53(3):210-6. PubMed ID: 21291464
    [Abstract] [Full Text] [Related]

  • 12. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study].
    Mousny M, Allington N.
    Rev Chir Orthop Reparatrice Appar Mot; 1999 May 22; 85(2):156-63. PubMed ID: 10392416
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Muscle volume alterations after first botulinum neurotoxin A treatment in children with cerebral palsy: a 6-month prospective cohort study.
    Alexander C, Elliott C, Valentine J, Stannage K, Bear N, Donnelly CJ, Shipman P, Reid S.
    Dev Med Child Neurol; 2018 Nov 22; 60(11):1165-1171. PubMed ID: 30151852
    [Abstract] [Full Text] [Related]

  • 16. Effects of botulinum toxin serotype A on sleep problems in children with cerebral palsy and on mothers sleep quality and depression.
    Binay Safer V, Ozbudak Demir S, Ozkan E, Demircioglu Guneri F.
    Neurosciences (Riyadh); 2016 Oct 22; 21(4):331-337. PubMed ID: 27744462
    [Abstract] [Full Text] [Related]

  • 17. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
    Yang TF, Fu CP, Kao NT, Chan RC, Chen SJ.
    Am J Phys Med Rehabil; 2003 Apr 22; 82(4):284-9. PubMed ID: 12649654
    [Abstract] [Full Text] [Related]

  • 18. Reduced Cross-Sectional Muscle Growth Six Months after Botulinum Toxin Type-A Injection in Children with Spastic Cerebral Palsy.
    De Beukelaer N, Weide G, Huyghe E, Vandekerckhove I, Hanssen B, Peeters N, Uytterhoeven J, Deschrevel J, Maes K, Corvelyn M, Costamagna D, Gayan-Ramirez G, Van Campenhout A, Desloovere K.
    Toxins (Basel); 2022 Feb 14; 14(2):. PubMed ID: 35202166
    [Abstract] [Full Text] [Related]

  • 19. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
    Lin YC, Lin IL, Chou TF, Lee HM.
    J Neuroeng Rehabil; 2016 Mar 12; 13():25. PubMed ID: 26969526
    [Abstract] [Full Text] [Related]

  • 20. Botulinum Toxin Type A Injection for Spastic Equinovarus Foot in Children with Spastic Cerebral Palsy: Effects on Gait and Foot Pressure Distribution.
    Choi JY, Jung S, Rha DW, Park ES.
    Yonsei Med J; 2016 Mar 12; 57(2):496-504. PubMed ID: 26847306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.